← FDA Drug Approvals (Drugs@FDA)

ANDA212283

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2026-02-04

Drug application

FDA Application #

ANDA212283

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

MANKIND PHARMA

First approval

2026-02-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown